Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company

Detalhes bibliográficos
Autor(a) principal: Bresolin, Tania Mari Bellé
Data de Publicação: 2020
Outros Autores: Silva, Ruth Meri Lucinda da, Meyre-Silva, Christiane, Quintão, Nara Lins Meira, Cechinel Filho, Valdir
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Fitos
Texto Completo: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935
Resumo: This work, of partnerships between a Community University and national pharmaceutical companies reports the development of new and effective phytotherapics obtained from the leaves of Aleurites mollucanus (Euphorbiaceae), an exotic species, from Asia, adapted in Brazil. The project, although it has not yet reached the final stage of clinical studies and registration with ANVISA, represents a relevant experience to be analyzed in light of the difficulties and overcomes during the stages that make up the chain of establishment of a new herbal medicine in Brazil. Tablets were developed based on the standardized dry extract of A. moluccanus, on pilot scale, with approval in the stages of non-clinical studies and in the clinical stage-phase I. In addition, formulations such as topical cream and oral suspension were established. The overcoming of challenges related to the standardization of the extract on an industrial scale, under good manufacturing practices (GMP) and the stability aspects of the formulations, the continuity of studies depends on the scenario and consequent market direction. Therefore, this report provides an insight into the setbacks and overcoming experienced by researchers from Brazilian Community University with a focus on research and development of new, effective and safe analgesic and anti-inflammatory herbal medicine.
id FIOCRUZ-1_46b14795f4959b6f142c25474eaadb40
oai_identifier_str oai:ojs.revistafitos.far.fiocruz.br:article/935
network_acronym_str FIOCRUZ-1
network_name_str Revista Fitos
repository_id_str
spelling Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical companyDesenvolvimento de fitoterápicos a partir das folhas da nogueira-da-índia (Aleurites moluccanus): relato de experiência de parceria entre uma Universidade Comunitária e indústrias farmacêuticas nacionaisAleurites mollucanusHerbal medicineCommunity UniversityTherapeutical innovationAnalgesy. InflammationAleurites mollucanusFitoterápicosUniversidade ComunitáriaInovação terapêuticaAnalgesiaInflamaçãoThis work, of partnerships between a Community University and national pharmaceutical companies reports the development of new and effective phytotherapics obtained from the leaves of Aleurites mollucanus (Euphorbiaceae), an exotic species, from Asia, adapted in Brazil. The project, although it has not yet reached the final stage of clinical studies and registration with ANVISA, represents a relevant experience to be analyzed in light of the difficulties and overcomes during the stages that make up the chain of establishment of a new herbal medicine in Brazil. Tablets were developed based on the standardized dry extract of A. moluccanus, on pilot scale, with approval in the stages of non-clinical studies and in the clinical stage-phase I. In addition, formulations such as topical cream and oral suspension were established. The overcoming of challenges related to the standardization of the extract on an industrial scale, under good manufacturing practices (GMP) and the stability aspects of the formulations, the continuity of studies depends on the scenario and consequent market direction. Therefore, this report provides an insight into the setbacks and overcoming experienced by researchers from Brazilian Community University with a focus on research and development of new, effective and safe analgesic and anti-inflammatory herbal medicine.Este trabalho, de parcerias entre uma Universidade Comunitária e empresas farmacêuticas nacionais relata o desenvolvimento de novos e efetivos fitoterápicos obtidos a partir das folhas de Aleurites mollucanus (Euphorbiaceae), uma espécie exótica, proveniente da Ásia, adaptada no Brasil. Este projeto, embora ainda não tenha alcançado o estágio final de estudos clínicos e registro junto à ANVISA, representa uma experiência relevante a ser analisada à luz das dificuldades e superações no decorrer das etapas que compõem a cadeia de estabelecimento de um novo medicamento fitoterápico no Brasil. Com aprovação nas etapas de estudos não clínicos e na etapa clínica-fase I foram desenvolvidos, em escala piloto, comprimidos a base do extrato seco padronizado de A. moluccanus. Além disso, foram estabelecidas formulações como creme tópico e suspensão oral. A superação dos desafios para padronização do extrato em escala industrial, sob boas práticas de fabricação (BPF) e os aspectos de estabilidade das formulações, assim como a continuidade dos estudos, depende do cenário e consequente direcionamento do mercado. Este relato proporcionou uma visão sobre os percalços e as superações vivenciadas por pesquisadores de uma Universidade Comunitária brasileira, com foco na pesquisa e desenvolvimento de novo, efetivo e seguro fitoterápico analgésico e anti-inflamatório.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2020-12-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/93510.32712/2446-4775.2020.935Revista Fitos; Vol. 14 No. 4 (2020); 538-546Revista Fitos; Vol. 14 Núm. 4 (2020); 538-546Revista Fitos; v. 14 n. 4 (2020); 538-5462446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935/758https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935/759Copyright (c) 2020 Revista Fitoshttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessBresolin, Tania Mari Bellé Silva, Ruth Meri Lucinda daMeyre-Silva, ChristianeQuintão, Nara Lins MeiraCechinel Filho, Valdir2020-12-18T10:45:56Zoai:ojs.revistafitos.far.fiocruz.br:article/935Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2020-12-18T10:45:56Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
Desenvolvimento de fitoterápicos a partir das folhas da nogueira-da-índia (Aleurites moluccanus): relato de experiência de parceria entre uma Universidade Comunitária e indústrias farmacêuticas nacionais
title Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
spellingShingle Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
Bresolin, Tania Mari Bellé
Aleurites mollucanus
Herbal medicine
Community University
Therapeutical innovation
Analgesy. Inflammation
Aleurites mollucanus
Fitoterápicos
Universidade Comunitária
Inovação terapêutica
Analgesia
Inflamação
title_short Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
title_full Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
title_fullStr Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
title_full_unstemmed Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
title_sort Development of herbal medicines from the leaves of the walnut tree (Aleurites moluccanus): report experience of Community University and national pharmaceutical company
author Bresolin, Tania Mari Bellé
author_facet Bresolin, Tania Mari Bellé
Silva, Ruth Meri Lucinda da
Meyre-Silva, Christiane
Quintão, Nara Lins Meira
Cechinel Filho, Valdir
author_role author
author2 Silva, Ruth Meri Lucinda da
Meyre-Silva, Christiane
Quintão, Nara Lins Meira
Cechinel Filho, Valdir
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bresolin, Tania Mari Bellé
Silva, Ruth Meri Lucinda da
Meyre-Silva, Christiane
Quintão, Nara Lins Meira
Cechinel Filho, Valdir
dc.subject.por.fl_str_mv Aleurites mollucanus
Herbal medicine
Community University
Therapeutical innovation
Analgesy. Inflammation
Aleurites mollucanus
Fitoterápicos
Universidade Comunitária
Inovação terapêutica
Analgesia
Inflamação
topic Aleurites mollucanus
Herbal medicine
Community University
Therapeutical innovation
Analgesy. Inflammation
Aleurites mollucanus
Fitoterápicos
Universidade Comunitária
Inovação terapêutica
Analgesia
Inflamação
description This work, of partnerships between a Community University and national pharmaceutical companies reports the development of new and effective phytotherapics obtained from the leaves of Aleurites mollucanus (Euphorbiaceae), an exotic species, from Asia, adapted in Brazil. The project, although it has not yet reached the final stage of clinical studies and registration with ANVISA, represents a relevant experience to be analyzed in light of the difficulties and overcomes during the stages that make up the chain of establishment of a new herbal medicine in Brazil. Tablets were developed based on the standardized dry extract of A. moluccanus, on pilot scale, with approval in the stages of non-clinical studies and in the clinical stage-phase I. In addition, formulations such as topical cream and oral suspension were established. The overcoming of challenges related to the standardization of the extract on an industrial scale, under good manufacturing practices (GMP) and the stability aspects of the formulations, the continuity of studies depends on the scenario and consequent market direction. Therefore, this report provides an insight into the setbacks and overcoming experienced by researchers from Brazilian Community University with a focus on research and development of new, effective and safe analgesic and anti-inflammatory herbal medicine.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-18
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935
10.32712/2446-4775.2020.935
url https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935
identifier_str_mv 10.32712/2446-4775.2020.935
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935/758
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/935/759
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Fitos
https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Fitos
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
dc.source.none.fl_str_mv Revista Fitos; Vol. 14 No. 4 (2020); 538-546
Revista Fitos; Vol. 14 Núm. 4 (2020); 538-546
Revista Fitos; v. 14 n. 4 (2020); 538-546
2446-4775
1808-9569
reponame:Revista Fitos
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Revista Fitos
collection Revista Fitos
repository.name.fl_str_mv Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br
_version_ 1798313475420717056